http://www.advfn.com/nasdaq/rss.asp NASDAQ Stock Market Company Newsfeed en Tue, 30 Jun 2009 13:22:19 EDT Tue, 30 Jun 2009 13:22:19 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SINO&article=38444858&headline=ny-comptroller-to-divest-86-2-million-in-state-pension-fund http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SINO&article=38444858&headline=ny-comptroller-to-divest-86-2-million-in-state-pension-fund <div class='newsbody'><pre> By Jillian Mincer Of DOW JONES NEWSWIRES </pre> <p> NEW YORK -(Dow Jones)- The enormous New York State Common Retirement Fund plans to divest $86.2 million in investments from nine companies doing business in Sudan and Iran. </p> <p> New York State Comptroller Thomas P. DiNapoli... Tue, 30 Jun 2009 13:22:19 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=38366143&headline=teva-ftc-savings-claims-in-data-makes-flawed-assumptions http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=38366143&headline=teva-ftc-savings-claims-in-data-makes-flawed-assumptions <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> A day after the Federal Trade Commission asserted that billions of dollars could be saved if settlements in which branded drug makers pay generic manufacturers to delay entry into the market were ended, the biggest generic player asserted the savings... Wed, 24 Jun 2009 15:39:09 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=38297652&headline=canadian-court-rejects-bid-to-make-generic-version-of-viagra http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=38297652&headline=canadian-court-rejects-bid-to-make-generic-version-of-viagra <div class='newsbody'><p> OTTAWA (AFP) -- A Canadian federal court Thursday upheld pharmaceutical giant Pfizer Inc.'s (PFE) patent for Viagra, dashing generic-drug maker Novopharm's longing for sales of cheaper erection drugs. </p> <p> Judge Michael Kelen said in his decision that Novopharm failed to... Thu, 18 Jun 2009 15:28:10 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37943074&headline=us-patent-office-to-re-examine-merck-singulair-patent http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37943074&headline=us-patent-office-to-re-examine-merck-singulair-patent <div class='newsbody'><pre> By Peter Loftus Of DOW JONES NEWSWIRES </pre> <p> The U.S. Patent and Trademark Office has ordered a re-examination of a key patent for Merck &amp; Co.'s (MRK) blockbuster Singulair allergy and asthma drug, saying new questions have been raised about its "patentability." </p> <p>... Thu, 28 May 2009 16:33:23 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37862658&headline=drug-makers-to-pay-89-million-to-settle-alabama-medicaid-price http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37862658&headline=drug-makers-to-pay-89-million-to-settle-alabama-medicaid-price <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Pharmaceutical companies agreed to pay an additional $89 million to Alabama in settlement of litigation against 72 companies accused of defrauding the state's Medicaid system by overcharging for drugs. </p> <p> The state already reached settlements... Fri, 22 May 2009 16:34:11 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37734538&headline=gilead-sciences-files-patent-infringements-suit-against-teva http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37734538&headline=gilead-sciences-files-patent-infringements-suit-against-teva <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Gilead Sciences Inc. (GILD) said on Thursday it filed a lawsuit against Israeli-based Teva Pharmaceutical Industries Inc. (TEVA) and its U.S. subsidiary for infringement of two patents tied to two of its HIV drugs. </p> <p> The action from Gilead... Thu, 14 May 2009 17:26:17 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=GGAL&article=37709074&headline=argentinas-conservative-isolated-banks-shrug-off-econ-woes http://www.advfn.com/nasdaq/StockNews.asp?stocknews=GGAL&article=37709074&headline=argentinas-conservative-isolated-banks-shrug-off-econ-woes <div class='newsbody'><p> By Michael Casey </p> <p> Of DOW JONES NEWSWIRES </p> <p> BUENOS AIRES -(Dow Jones)- If investors reviewing the latest quarterly earnings from Argentine banks didn't know otherwise, they would find it hard to believe the country was facing twin local and international crises... Wed, 13 May 2009 12:58:23 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37707713&headline=appeals-court-upholds-procter-gamble-patent-rights-on-actonel http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37707713&headline=appeals-court-upholds-procter-gamble-patent-rights-on-actonel <div class='newsbody'><pre> By Brent Kendall Of DOW JONES NEWSWIRES </pre> <p> WASHINGTON -(Dow Jones)- A federal appeals court Wednesday upheld a lower court ruling that protected Procter &amp; Gamble Co.'s (PG) patent rights to osteoporosis drug Actonel, which were under attack from generic competitor... Wed, 13 May 2009 11:50:05 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37411598&headline=lilly-seen-as-winner-in-courts-block-of-generic-bone-drug http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37411598&headline=lilly-seen-as-winner-in-courts-block-of-generic-bone-drug <div class='newsbody'><pre> By Thomas Gryta Of DOW JONES NEWSWIRES </pre> <p> NEW YORK -(Dow Jones)- A ruling that temporarily blocks Teva Pharmaceutical Industries Ltd. (TEVA) from selling a generic version of Eli Lilly &amp; Co.'s (LLY) blockbuster osteoporosis drug Evista may provide insights into... Thu, 23 Apr 2009 13:36:06 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37410861&headline=eu-panel-teva-pharma-wont-continue-marketing-strategy http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37410861&headline=eu-panel-teva-pharma-wont-continue-marketing-strategy <div class='newsbody'><p> Edited Press Release </p> <p> LONDON -(Dow Jones)- The European Medicines Agency said today that it has been formally notified by Teva Pharma B.V. of its decision to withdraw its application for a centralised marketing authorisation for Clopidogrel Teva Pharma (clopidogrel hydrobromide... Thu, 23 Apr 2009 12:53:04 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37396187&headline=fda-will-allow-17-year-olds-access-to-plan-b-pill http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37396187&headline=fda-will-allow-17-year-olds-access-to-plan-b-pill <div class='newsbody'><pre> By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES </pre> <p> WASHINGTON -(Dow Jones)- The Food and Drug Administration will allow 17-year-olds access to the Plan B emergency-contraceptive pill without a prescription. </p> <p> The decision, which complies with a federal court... Wed, 22 Apr 2009 17:44:11 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37337380&headline=eli-lilly-expected-to-report-higher-1q-earnings-sales-monday http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37337380&headline=eli-lilly-expected-to-report-higher-1q-earnings-sales-monday <div class='newsbody'><p> By Val Brickates Kennedy </p> <p> Eli Lilly &amp; Co. is expected to post higher first-quarter earnings when it rolls out its report early Monday, due in part to strong sales growth for its antidepressant Cymbalta and lung cancer treatment Alimta. </p> <p> According to a poll... Fri, 17 Apr 2009 19:19:35 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SNTS&article=37329958&headline=senegal-unions-threaten-strike-over-sale-to-france-telecom http://www.advfn.com/nasdaq/StockNews.asp?stocknews=SNTS&article=37329958&headline=senegal-unions-threaten-strike-over-sale-to-france-telecom <div class='newsbody'><p> DAKAR, Senegal (AFP)--Unions for Sonatel, Senegal's biggest telecom operator, Friday threatened to call a strike to prevent France Telecom SA (FTE) from getting a 52.2%controlling stake in the company. </p> <p> Denouncing what they called "a decolonization of the telecoms system... Fri, 17 Apr 2009 09:14:07 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37201357&headline=gilead-reviews-tevas-generic-application-may-file-suit http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=37201357&headline=gilead-reviews-tevas-generic-application-may-file-suit <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> Gilead Sciences Inc. (GILD) said it is reviewing a notice letter and has 45 days to file a patent infringement lawsuit against Teva Pharmaceutical Industries Ltd. (TEVA), following Teva's submission to manufacture and market a generic version... Mon, 06 Apr 2009 18:08:14 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=FSCI&article=37045999&headline=former-sec-chairman-breeden-disagrees-with-treasury-seizure-plan http://www.advfn.com/nasdaq/StockNews.asp?stocknews=FSCI&article=37045999&headline=former-sec-chairman-breeden-disagrees-with-treasury-seizure-plan <div class='newsbody'><pre> By Sarah N. Lynch Of DOW JONES NEWSWIRES </pre> <p> WASHINGTON -(Dow Jones)- Former Securities and Exchange Commission Chairman Richard Breeden said Thursday he doesn't like the U.S. Treasury's new plan to allow the government to seize troubled non-bank financial firms and... Thu, 26 Mar 2009 13:35:02 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36934271&headline=medicis-teva-agree-to-halt-legal-disputes-over-solodyn http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36934271&headline=medicis-teva-agree-to-halt-legal-disputes-over-solodyn <div class='newsbody'><p> DOW JONES NEWSWIRES </p> <p> Medicis Pharmaceutical Corp. (MRX) and Teva Pharmaceutical Industries Ltd. (TEVA) late Wednesday said they have agreed to halt all legal disputes between them over Medicis' Solodyn Extended Release tablets, which are used to treat acne. </p> <p>... Wed, 18 Mar 2009 23:03:15 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36788980&headline=independent-firm-seeks-review-of-mercks-singulair-patent http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36788980&headline=independent-firm-seeks-review-of-mercks-singulair-patent <div class='newsbody'><pre> DOW JONES NEWSWIRES </pre> <p> A firm that specializes in challenging the validity of patents has requested the U.S. Patent Office review a patent for Merck &amp; Co.'s (MRK) Singulair that is being contested by Teva Pharmaceuticals Industries Ltd. (TEVA). </p> <p> Independent... Mon, 09 Mar 2009 00:31:48 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36392978&headline=lilly-wins-ruling-delaying-teva-bid-to-market-generic-evista http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36392978&headline=lilly-wins-ruling-delaying-teva-bid-to-market-generic-evista <div class='newsbody'><pre> By Brent Kendall Of DOW JONES NEWSWIRES </pre> <p> WASHINGTON -(Dow Jones)- A federal appeals court on Tuesday upheld a trial judge's decision to delay Teva Pharmaceutical Industries Ltd.'s (TEVA) bid to market a generic version of Eli Lilly &amp; Co.'s (LLY) blockbuster osteoporosis... Tue, 24 Feb 2009 12:32:04 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36376326&headline=merck-tells-of-tortured-path-toward-making-asthma-drug http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36376326&headline=merck-tells-of-tortured-path-toward-making-asthma-drug <div class='newsbody'><pre> By Peter Loftus and Thomas Gryta Of DOW JONES NEWSWIRES </pre> <p> TRENTON, N.J. -(Dow Jones)- Merck &amp; Co. (MRK) took a "tortured path" in developing its blockbuster asthma and allergy drug Singulair, a lawyer for the company told a judge Monday in an effort to ward off... Mon, 23 Feb 2009 12:47:07 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36333320&headline=shire-4q-sales-rise-6-reiterates-2009-forecast http://www.advfn.com/nasdaq/StockNews.asp?stocknews=TEVA&article=36333320&headline=shire-4q-sales-rise-6-reiterates-2009-forecast <div class='newsbody'><pre> By Elena Berton Of DOW JONES NEWSWIRES </pre> <p> LONDON -(Dow Jones)- Shire PLC (SHPGY) Thursday said that fourth-quarter sales rose 6% on strong sales of hyperactivity drug Vyvanse as well as other newer medicines, and reiterated its previous forecast for 2009. </p> <p>... Thu, 19 Feb 2009 08:05:08 EST